Xeris Biopharma Holdings Inc (XERS)

Capital Expenditure

-$1.23M

TTM · Period ending: · USD

XERS logo

XERS Capital Expenditure

Latest reported-$1.23M
XERS TTM CapEx (-$700.00K → -$1.23M)
High-resolution chart · PNG

XERS capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Xeris Biopharma Holdings Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-1,230,000
-1,300,000
-988,000
-875,000
-599,000
-717,000
-868,000
-780,000
-1,038,000
-2,189,000
-2,263,000
-2,263,000
-2,094,000
-762,000
-524,000
-523,000
-654,000
-656,000
-1,085,000
-1,179,000
-872,000
-800,000
-397,000
-416,000
-785,000
-933,000
-1,107,000
-1,113,000
-1,515,000
-1,377,000
-1,510,000
-1,496,000
-750,000
-691,000
-700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.